Preclinical insights into cholangiopathies: disease modeling and emerging therapeutic targets-Reference-Cited by-同舟云学术

Preclinical insights into cholangiopathies: disease modeling and emerging therapeutic targets

Published:2019-04-22 Issue:6 Volume:23 Page:461-472
ISSN:1472-8222
Container-title:Expert Opinion on Therapeutic Targets
language:en
Short-container-title:Expert Opinion on Therapeutic Targets

Author:

Sato Keisaku¹²,Glaser Shannon³,Kennedy Lindsey¹²,Liangpunsakul Suthat¹²,Meng Fanyin¹²,Francis Heather¹²,Alpini Gianfranco¹²

Affiliation:

1. Indiana Center for Liver Research, Division of Gastroenterology & Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA

2. Richard L. Roudebush VA Medical Center, Indianapolis, IN, USA

3. Department of Medical Physiology, Texas A&M University Collage of Medicine, Temple, TX, USA

Funder

NIH

VA Merit award

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728222.2019.1608950

Reference144 articles.

1. Primary Sclerosing Cholangitis

2. Primary sclerosing cholangitis: diagnostic and management challenges

3. Primary sclerosing cholangitis

4. Primary sclerosing cholangitis – a comprehensive review

5. Diagnosis of cholangiocarcinoma in primary sclerosing cholangitis

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-Cell Transcriptomic Profiling of Cholangiocyte Organoids Derived from Bile Ducts of Primary Sclerosing Cholangitis Patients;Digestive Diseases and Sciences;2024-08-19

2. Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications;Medical Review;2024-07-01

3. Navigating the liver landscape: upcoming pharmacotherapies for primary sclerosing cholangitis;Expert Opinion on Pharmacotherapy;2024-05-02

4. Cholangiocyte Organoids: The New Frontier in Regenerative Medicine for the Study and Treatment of Cholangiopathies;Journal of Clinical Medicine;2024-03-21

5. Novel preclinical developments of the primary sclerosing cholangitis treatment landscape;Expert Opinion on Investigational Drugs;2024-03-18